Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in QTTB — Q32 Bio Inc.

CIK 72971 SAN FRANCISCO, CA
Back to QTTB Full portfolio

Position in QTTB

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$539
+$332 QoQ
Shares Held
84
-39.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QTTB Over Time

Shares Held

Position Value (USD)

Derivatives in QTTB

reported options exposure · as of Mar 31, 2022
CallValue
$0
CallShares
4,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in QTTB

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $539 84
2025-06-30 $207 139
2025-03-31 $6,035 3,658
2024-12-31 $12,308 3,578
2024-09-30 $123,998 2,779
2024-06-30 $48,949 2,727
2024-03-31 $1,346 79